FFAR3 and colitis: Our results showed that EcN treatment promoted the expansion of SCFA-producing bacteria, significantly restored the normal fecal levels of acetic acid and butyric acid, and upregulated the expression of GPR41/43, receptors of SCFAs, in colonic tissues of mice with colitis.